Harvard Bioscience, Inc. Forecast, price target & analysts
Harvard Bioscience, Inc. Target price 2025 - Analyst rating & recommendation
Harvard Bioscience, Inc. Classifications & Recommendation:
Harvard Bioscience, Inc. Price Target
| Target Price | $4.50 |
| Price | $0.39 |
| Potential |
1,053.85%
register free of charge
|
| Number of Estimates | 1 |
|
1 Analyst has issued a Harvard Bioscience, Inc. price target 2026.
The average Harvard Bioscience, Inc. target price is $4.50.
This is
1,053.85%
register free of charge
|
|
| A rating was issued by 2 analysts: 1 Analysts recommend Harvard Bioscience, Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Harvard Bioscience, Inc. stock has an average upside potential 2026 of
1,053.85%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 94.14 | 88.55 |
| 16.13% | 5.94% | |
| EBITDA Margin | 2.53% | 7.96% |
| 69.42% | 214.85% | |
| Net Margin | -13.11% | -8.71% |
| 317.33% | 33.55% |
2 Analysts have issued a sales forecast Harvard Bioscience, Inc. 2025 . The average Harvard Bioscience, Inc. sales estimate is
This results in the following potential growth metrics:
2 Analysts have issued an Harvard Bioscience, Inc. EBITDA forecast 2025. The average Harvard Bioscience, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Harvard Bioscience, Inc. Analysts have issued a net profit forecast 2025. The average Harvard Bioscience, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.28 | -0.18 |
| 250.00% | 35.71% | |
| P/E | negative | |
| EV/Sales | 0.65 |
2 Analysts have issued a Harvard Bioscience, Inc. forecast for earnings per share. The average Harvard Bioscience, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Harvard Bioscience, Inc....
Current Harvard Bioscience, Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Keybanc |
Locked
➜
Locked
|
Locked | Apr 09 2025 |
| Keybanc |
Locked
➜
Locked
|
Locked | Apr 08 2025 |
| Benchmark |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 09 2025 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Apr 08 2025 |
|
Locked
Benchmark:
Locked
➜
Locked
|
Mar 24 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
